A panel of experts on relapsed/refractory multiple myeloma review clinical trial data on novel therapies and drug combinations and discuss treatment decision-making and sequencing practices.
EP. 1: Clinical Scenario 1: A 67-Year-Old Man with Multiple Myeloma
A panel of myeloma specialists review the case of a 67-year-old patient with multiple myeloma (MM) who received a bispecific antibody.
EP. 2: Treatment Options in Late-line R/R MM Patients
Following the presentation of a case of a patient with multiple myeloma, the panel have a roundtable discussion on how to approach treatment.